lupus
Exagen Q1 Revenues Grow 10 Percent
Revenues from testing were $10.3 million, up from $9.6 million on increased testing volume.
Exagen, Allegheny Health Network Research and Autoimmunity Institutes Partner on Autoimmune Tests
Exagen will get a worldwide exclusive license to four families of inventions and the Autoimmunity Institute's clinical biobank.
Exagen, Emory University to Study of Long-Term Effects of COVID-19 on Autoimmune Disease
The study will evaluate the emergence of biomarkers that are indicators for autoimmune diseases and assess these biomarkers in mild and moderate COVID-19 patients.
Exagen Q4 2020 Revenues Up 24 Percent, Full Year Revenues Grow 4 Percent
The company's fourth quarter revenues rose to $12.7 million, while full year revenues rose to $42 million.
DiaSorin, Roche, Inova Diagnostics Receive FDA 510(k) Clearances in February
DiaSorin got the green light for its Liaison Anti-HAV chemiluminescent immunoassay to detect total antibodies to the hepatitis A virus.
Nov 25, 2019
Nov 12, 2019
Exagen Q3 Revenues Rise 27 Percent
Oct 14, 2019
William Blair, Cowen Initiate Coverage of Exagen
Sep 19, 2019
Exagen Goes Public at $14 per Share
Aug 14, 2019
Salveo Dx Merges With ImmunArray, Nudge
Aug 20, 2018
CareFirst BCBS, Exagen Partner to Evaluate Lupus Dx
Jun 5, 2018
Mar 15, 2018